Abstract:Bioengineered bladder tissue is needed for patients with neurogenic bladder disease as well as for cancer. Current technologies in bladder tissue engineering have been hampered by an inability to efficiently initiate blood supply to the graft, ultimately leading to complications that include graft contraction, ischemia, and perforation. To date, the biological mechanisms of vascularization on transplant have not been suitably investigated for urologic tissues. To better understand the mechanisms of neovascularization on bladder wall transplant, a chimeric mouse model was generated such that angiogenesis and vasculogenesis could be independently assessed in vivo. Green fluorescence protein (GFP) transgenic mice received bone marrow transplants from β-galactosidase (LacZ) transgenic animals and then subsequent bladder wall transplants from wild-type donor mice. Before euthanization, the aorta was infused with fluorescent microbeads (fluorospheres) to identify perfused vessels. The contributions of GFP (angiogenesis) and LacZ (vasculogenesis) to the formation of CD31-expressing blood vessels within the wild-type graft were evaluated by immunohistochemistry at different time points and locations within the graft (proximal, middle, and distal) to provide a spatiotemporal analysis of neovascularization. The GFP index, a measure of angiogenic host ingrowth, was significantly higher at proximal versus mid or distal regions in animals 2-16 weeks post-transplant. However, GFP index did not increase over time in any area. Within 7 days post-transplant, perfusion of primarily wild-type, donor blood vessels in the most distal areas of the graft was observed by intraluminal fluorospheres. In addition, chimeric host-donor (GFP-wild type) blood vessels were evident in proximal areas. The contribution of vasculogenesis to vascularization of the graft was limited, as LacZ cells were not specifically associated with the endothelial cells of blood vessels, but rather found primarily in areas of inflammation. The data suggest that angiogenesis of host blood vessels into the proximal region leads to inosculation between host and donor vessels and subsequent perfusion of the graft via pre-existing graft vessels within the first week after transplant. As such, the engineering of graft blood vessels and the promotion of inosculation might prevent graft contraction, thereby potentiating the use of bioengineered bladder tissue for transplantation.

Bioengineering of Intestinal Grafts

Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art Biologicals in Intestinal Transplantation

Gut bioengineering promotes gut repair and pharmaceutical research: a review

Use of Decellularized Bio-Scaffolds for the Generation of a Porcine Artificial Intestine

Progress in bioreactors of bioartificial livers.

Basic Principles of Bioengineering and Regeneration

Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.

New insights in intestinal ischemia-reperfusion injury: implications for intestinal transplantation

B-Cell Induction Therapies in Intestinal Transplantation

Early clinical and histologic viability of human liver‐small intestinal allografts after implantation

Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall

Two-step Procedure of Whole Orthotopic Intestinal Transplantation in Rats: Considerations of Techniques and Graft Functional Adaptation.

A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression

Biofabrication of Vital Parenchymal Organs

Intestinal transplantation: Significance of immune responses

Bioengineering Human Tissues and the Future of Vascular Replacement

Bioengineering the Human Intestinal Mucosa and the Importance of Stromal Support for Pharmacological Evaluation In Vitro

Tissue Engineering of Blood Vessel.

Development of a Silk Fibroin-Small Intestinal Submucosa Small-Diameter Vascular Graft with Sequential VEGF and TGF-β1 Inhibitor Delivery for In Situ Tissue Engineering

Whole Organ Engineering: Approaches, Challenges, and Future Directions

Multifunctional Bioreactor System for Human Intestine Tissues.